Heart Test Laboratories Inc
NASDAQ:HSCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (822.2), the stock would be worth $4.26 (115% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 382.6 | $1.98 |
0%
|
| 3-Year Average | 822.2 | $4.26 |
+115%
|
| 5-Year Average | 16 954.1 | $87.74 |
+4 331%
|
| Industry Average | 2.1 | $0.01 |
-99%
|
| Country Average | 3 | $0.02 |
-99%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
$4.2m
|
/ |
Feb 2026
$8.7k
|
= |
|
|
$4.2m
|
/ |
Apr 2027
$364.7k
|
= |
|
|
$4.2m
|
/ |
Apr 2028
$3.2m
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Heart Test Laboratories Inc
NASDAQ:HSCS
|
6.3m USD | 382.6 | -0.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 15.4 | 56.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 3.5 | 25.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 5.2 | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 3.4 | 22.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 4.6 | 23.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 6.9 | 43 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
38.3B EUR | 2 | 18.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 10.3 | 41.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 2.6 | 23.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 5.5 | 20.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 3 |
| 70th Percentile | 5.3 |
| Max | 4 613 320.1 |
Other Multiples
Heart Test Laboratories Inc
Glance View
Heart Test Laboratories Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Southlake, Texas and currently employs 12 full-time employees. The company went IPO on 2022-06-15. Heart Test Laboratories, Inc. is a medical technology company focused on developing artificial intelligence (AI) based technology to an electrocardiogram (ECG) to expand and improve an ECG’s clinical usefulness. The Company’s product candidate, the MyoVista wavECG, or the MyoVista, is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista is a 12-lead resting ECG device that features its algorithm developed to detect cardiac dysfunction in the diastolic phase, specifically slower than normal left ventricular relaxation rates. The MyoVista uses electrical information from the heart captured during a standard resting 12-lead ECG test as inputs to an artificial intelligence-based algorithm. The MyoVista detects whether a patient is negative or positive for abnormally slow left ventricular diastolic relaxation rates.
